IOIBD * report no 1: observer variation in calculating indices of severity and activity in Crohn's disease F T DE DOMBAL AND A SOFTLEY SUMMARY Observer variation in calculating various indices for estimating the severity and activity of Crohn's disease is reported. Seven prospective users of Crohn's disease activity indices were presented with 10 'cases histories' compiled from relevant patient data and asked to calculate (independently) various indices of severity and activity from this information. The results showed a disquieting degree of observer variation in all indices studied. Similar results were obtained when 15 members of the International Organisation for the Study of Inflammatory Bowel Disease (IOIBD) reviewed one case history and also when members independently reviewed a series of real life cases. It is suggested that each index so far proposed is open to considerable observer variation, which casts some doubt upon the validity of studies so far carried out. Clarification of indices and the use of ranking methods can, however, do much to overcome this discrepancy.
Rapid, reliable, and reproducible estimation of the severity and activity of Crohn's disease at a given time ranks second only in importance to accuracy of diagnosis in its implications -both for the management of an individual patient and for the conduct of clinical therapeutic trials.
In the 1970's a major step forward was taken with the development of the Crohn's disease Activity Index (CDAI) for use in the National Cooperative Crohn's Disease Study' (NCCD), to allow uniform decentralised clinical evaluation and decision making throughout the period of the study. 2 The original CDAI has since undergone modification by Harvey and Bradshaw,3 by the World Organisation of Gastroenterology,4 and by the NCCD authors themselves.' Other indices (or lists of factors affecting severity) have been published,`8 or widely communicated (Table 1 ). Yet there is a lack of study relating to the reproducibility of each index; and the practical value of an index which is poorly reproducible must be open to considerable question. An In this report from the International Organisation for the Study of Inflammatory Bowel Disease (IOIBD) we present the result of studies designed to explore both points.
Methods

MATERIAL
There were four 'parts' to the present study -the first three deal with calculation of indices, the fourth with elicitation of patient data.
Part 1
The first part of this study involved a group of seven prospective users of Crohn's Disease Activity Indices (five consultants in surgery or gastroenterology, and two research assistants). Each was provided with 10 'case histories' (Fig. 1 ) and asked to calculate (for each 'patient'), eight indices of severity.
Part 2
Next, 15 clinicians attending the 1984 (Copenhagen) meeting of the IOIBD were presented with case data from a single 'patient' (Fig. 1) , and asked to calculate each of eight indices for this 'patient'. IOIBD* reportno 1: observer variation in calculating indices ofseverity and activity in Crohn's disease to determine which items were responsible for the interobserver variation (Table 3) .
The items given rise to most variation were number of liquid stools per day (due to dissention as to what constitutes a liquid stool), complications (some observers felt the given list to be incomplete, and added their own complications), the haematocrit ('rules of thumb' for calculating this differ from country to country) and the weight deficit (the method of calculating ideal weight varies from country to country). The biggest single problem, however, was inherent in the CDAI itself. For in the CDAI scheme indi- (Fig. 3) . The results at first sight show less interobserver variation, yet this is misleading, for the possible range of values is far smaller than the CDAI, and the variation is just as high (expressed as a percentage of the median level).
The effect of this variation is, in practice, considerable. If an arbitrary cutoff between 'active' and 'inactive' disease is set at a score of 8 (and a cutoff between 'moderate' and 'severe' disease at 16), around 10% of patients in any given series will be 'misclassified' (because of interobserver variation). Holland6 showed a totally different pattern of observer variation (Fig. 4) . Most observers were able to calculate to within one or two points, the precise value of this Index. Nevertheless two out of seven subjects apparently failed to understand the method of calculation and produced consistent (but totally erroneous) estimations.
Other indices studied were the 'Best-Becktel-B' Index' and the Index proposed by the Cape Town group (personal communication). Observer variation for these two indices was also considerable.
The final 'Index' tested was that proposed by the Study Group which later formed the IOIBD. This merely consisted of a list of 10 factors thought to be important by members of the Study Group. As might be expected there was good observer agreement in recording this, 95% of all estimates lying within one of the consensus mean score for each patient. (the figure arrived at by the instigators of the index themselves, who participated in the study), whereas other estimations ranged up to 417 (twice this value).
PART 3 FURTHER ANAL YSIS BY PROSPECTIVE USERS AFTER DISCUSSION
As a result, considerable discussion about definition of terminology took place. Subsequently a further seven prospective users repeated the study described in Part 1. Figure 6 illustrates the CDAI calculations by seven observers participating in the repeat study. There was considerable reduction in interobserver variation; the scatter was considerably less in almost all patients than that observed in Part 1 (see Table 2 ).
The results as regards other indices of activity were very similar. In particular, this applied to the Dutch Activity Index (where six of the seven observers produced virtually identical scores) and the South African and 'Best-Becktel-B' indices (which still showed considerable interobserver variation).
The repeat study also compared three individuals who had participated in both Parts 1 and 3 (Fig. 7) . These data also suggested that the effects of discussion and previous definitions of terminology may be quite considerable.
IMPORTANCE OF RANKING
Previous studies have explored the use of ranking methods of analysis;' and when this is done, the findings become more favourable. Table 5 shows the consensus ranking of patients (from least severe to most severe) and the individual ranking of each observer. The independently -on the same day (Fig. 8) . There was wide variation in individual assessments of the CDAI -particularly in respect of patient 5 (where estimates ranged from 50 to 500). In only two patients was there 'good agreement', and even here, there was in each case a variation of over 50 points between the highest and lowest estimations. As regards the Dutch AI, far closer estimates were obtained, marred only by occasional wide discrepancies by individual single observers. Other indices calculated showed similar variation to the CDAI.
Discussion
No evaluation can ever determine that an index is 'valid'; only that an index may be useful in clinical work and/or therapeutic trials. If an index cannot be reproducibly calculated by those for whom it is designed then its subsequent use in clinical or research work will be less than optimal. As with any other evaluation, it is possible to level criticisms at the present study. Thus, it is possible to argue that the observers were unrepresentative, and lacked competence or lacked adequate guidance. Yet the observers were carefully chosen, being either typical prospective users of indices, or those with considerable experience and interest in the field, and all were provided with the authors' original descriptions of each index. All appeared to understand these.
It is also possible to argue that the statistical analysis of the resultant data is imprecise (see Appendix 2). But no statistical consideration can disguise the very considerable degree of observer variation noted in the present trial in calculating the various indices from identical information bases. This ranges from practical matters of detail (such as what constitutes a 'complication', how one calculates haematocrit levels, and how one works out ideal weights), to complete failure (in some instances) to understand the index in question by the subject under study.
In the present study a considerable effort was made to involve those who would be actual users Kruskalt' produced an identical statistic (which they called lambda), whilst Guttmanll had also suggested a 'comparable' (lambda) statistic (which was quite differently defined, as was the 'comparable' (pi) statistic of Scott). 12 In this context both Saigert3 and Schleff'4 have pointed out that it is not the mere presence of observer variation, but its magnitude and its effect in practical terms, which are the critical features to be measured. This view is supported by many authorities, such as Norbert Weiner. '5 For these reasons (as will be apparent from the Tables  and Figures) we have chosen (in lieu of complex and potentially fallible statistical analysis) to set out our results rather fully and to use simple non-parametric analyses wherever possible (such as median and range of estimations made). Also, as observer variation in this study is due to (a) poor calculation and (b) complete failure to understand the indices concerned, there are two types of discrepancy, slight random variation between estimates, and consistently large errors (Figs 2 and 4) . In order to take this into account, we have (in addition to the range of estimations) measured (for each assessment) the 'scatter' of estimation -that is once the highest and lowest values for each estimation have been excluded. This 'scatter' of estimation (roughly corresponding to an interquartile range in Parts 1 and 3) probably represents a more realistic assessment of what informed observers should be able to record in clinical practice in the given circumstances.
Naturally, this type of assessment biases the analysis quite strongly in favour of each index. Yet the observer variation is still relatively large, despite this bias -and thus this form of analysis in no way invalidates the major conclusions in this study.
The 'numerical' data from this study are not parametric data; and hence there is (as stated) a need for nonparametric methods of expression (such as median and range). This feature of the data, however, also underlines the importance of the use of ranking methods (such as those suggested by the NCCD authors themselves. ' Finally, the data from this study undoubtedly reveal a major deficiency in the use of discriminants for calculating indices which relate to situations in clinical medicine where there is likely to be significant observer variation. For example, Table 3 , even where there is only slight observer variation this may lead to considerable discrepancy between the final CDAI estimates produced -because each observer variation is magnified by a factor of up to 20. This problem must be taken into account in the construction of any future indices.
